Baclofen (Fluoroquinolone) is a skeletal muscle relaxant that is commonly prescribed for spasticity associated with multiple sclerosis, spinal cord injury, and other muscle disorders. It has been approved by the FDA for use in the management of muscle spasms and is available in tablet form for injection.
Baclofen is available in multiple forms, including oral, sublingual, and intrathecal. The oral form is commonly used for muscle spasticity, but can be administered as an intravenous (i.v.) infusion over an extended period of time.
Administer the medication by opening the patient’s mouth, squeezing the end of the oral syringe, or by directly drawing the plunger through the mouthpiece.
Baclofen may also be used in the following situations:
Baclofen should not be used in patients with a history of kidney problems, liver or heart problems, or who have had a recent history of liver or kidney disease. Inform your doctor if you are using baclofen or are taking other medications that can affect the metabolism of baclofen, including baclofen and other CNS depressants. Inform your doctor if you are taking theophylline, aminophylline, other centrally acting medications (eg, beta blockers, antifungals), or nonsteroidal anti-inflammatory drugs (NSAIDs), and if you have a history of blood disorders.
Baclofen may be used during pregnancy if the potential benefit outweighs the risks.
Baclofen is contraindicated in patients with known hypersensitivity to baclofen, or in those with a history of hypersensitivity reactions to baclofen or other skeletal muscle relaxants.
The safety of baclofen during pregnancy has not been established.
The following dosage forms are available:
The standard dose for the management of spasticity in the spinal cord is 500 mg every 8 hours given as 10 mg, then increasing to a maximum of 1000 mg daily. The dosage may be adjusted according to the severity of the muscle spasticity.
Elderly patients should not use baclofen, as it may increase the risk of complications including dementia, cognitive impairment, and diabetes. Inform your doctor of any other medications that your age or medical history suggests you may be taking.
The safety of baclofen in elderly patients has not been established. Inform your doctor if you are using baclofen and are on other medications that can alter its metabolism or increase the risk of complications. Your doctor will need to adjust your dosage based on the severity of your muscle spasticity and other factors. Always follow your doctor’s instructions.
For optimal results, the dose of baclofen should be adjusted according to the severity of muscle spasticity. Dosages higher than the therapeutic dose (e.g., 500 mg every 8 hours) should be used cautiously.
In certain cases, the dose may be adjusted based on the severity of muscle spasticity, weight gain, and the presence of other risk factors for muscle spasticity, including:
Baclofen Tablet is used to treat muscle spasms caused by neurological or spinal cord diseases, such as multiple sclerosis, cerebral palsy, Parkinson’s disease, or other neurological disorders such as multiple sclerosis. It works by decreasing the production of dopamine and norepinephrine in the brain.
Uses
Baclofen Tablet treats muscle spasms caused by multiple sclerosis, cerebral palsy, Parkinson’s disease, or other neurological disorders such as multiple sclerosis. It also relieves pain and reduces inflammation (swelling) caused by these diseases.
Composition
Baclofen Tablet is given as a tablet to be taken by mouth. The recommended starting dose is 10 mg (baclofen 20 mg), taken with a meal. It may take a few weeks to see the maximum effect.
Benefits
How to Use:
Storage
Store at room temperature between 15-30°C (59-86°F) away from heat, moisture, and dampness. Keep the tablet out of reach of children.
Disclaimer
We provide only general information about medications, including substances with no connection to the United States Food and Drug Administration. Information communication with the United States Food and Drug Administration is not intended to substitute for professional medical advice, diagnosis, or treatment. Always consult with a health care professional before starting or stopping any medication.
http://www.meds.fdi.gov/drugsatfda/drugsatfda_224_4.pdf Alcohol/food/alcohol are not included in the prices listed. See our for more information.Baclofen, a medication commonly used to treat muscle spasms and stiffness, has been a game-changer in the treatment of conditions such as Alzheimer's disease and dementia. In this article, we will explore the benefits of baclofen and provide you with the right information to make informed decisions about your health.
Baclofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat conditions such as spasticity, stiffness, and muscle spasms. It belongs to a class of drugs called, which work by decreasing inflammation and relieving pain.
Baclofen works by blocking the enzyme that produces prostaglandins, the chemicals produced in your body. These chemicals play a crucial role in managing inflammation and reducing swelling. By inhibiting their production, Baclofen helps alleviate symptoms and alleviate the strain on your muscles.
Like all medications, Baclofen can cause side effects, although not everyone will experience them. Common side effects of Baclofen may include headache, upset stomach, and muscle pain. In rare cases, more serious side effects like allergic reactions, liver problems, and kidney problems are possible.
While taking Baclofen is generally safe, there are potential side effects that may occur. Common side effects include headache, nausea, and vomiting. If you experience any of these side effects, stop taking the medication and see your healthcare provider.
Baclofen belongs to the class of medications called skeletal muscle relaxants. It is used totreat pain and stiffness associated with muscle spasms (muscle spasticity).It helps torestore the body's natural balanceby relieving muscle stiffness caused by injury, surgery, or disease.
This medication may be available under multiple brand names and/or in several different forms.Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of this medication may not be used for all of the conditions discussed here.
Your doctor may have suggested this medication for conditions other than those listed in these drug information articles.If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor.Do not stop taking this medication without consulting your doctor.
Do not give this medication to anyone else, even if they have the same symptoms as you do.It can be harmful for people to take this medication if their doctor has not prescribed it.
250 mgEach white, blue, diamond-shaped tablet, debossed with "N" on one side and "T" on the other side, contains Baclofen 10 mgorally. These tablets are scored and imprinted with the trademark "P" on one side and "T" on the other side.Each tablet contains Baclofen equivalent to10 mg of Baclofen.60 mg of Baclofen.100 mg of Baclofen.200 mg of Baclofen.400 mg of Baclofen.600 mg of Baclofen.1 mg of Baclofen.0.25 mg of Baclofen.0.5 mg of Baclofen.0.75 mg of Baclofen.2 mg of Baclofen.3 mg of Baclofen.7 mg of Baclofen.8 mg of Baclofen.12.5 mg of Baclofen.20 mg of Baclofen.40 mg of Baclofen.
Li, Alison. "5 Marketing Menopause: Science and the Public Relations of Baclofen".
Women, Health, and Nation: Canada and the United States since 1945, edited by Georgina Feldberg, Molly Ladd-Taylor, Alison Li and Kathryn McPherson, Montreal: McGill-Queen's University Press, 2003, pp. 101-120.
Li, A. (2003). 5 Marketing Menopause: Science and the Public Relations of Baclofen. In G. Feldberg, M. Ladd-Taylor, A. Li & K. McPherson (Ed.),
(pp. 101-120). Montreal: McGill-Queen's University Press.
2003. In: Feldberg, G., Ladd-Taylor, M., Li, A. and McPherson, K. ed.
. Montreal: McGill-Queen's University Press, pp.
"5 Marketing Menopause: Science and the Public Relations of Baclofen" In
edited by Georgina Feldberg, Molly Ladd-Taylor, Alison Li and Kathryn McPherson, 101-120. Montreal: McGill-Queen's University Press, 2003.
Li A. In: Feldberg G, Ladd-Taylor M, Li A, McPherson K (ed.)
Montreal: McGill-Queen's University Press; 2003. p.101-120.
Copied to clipboard
CopyExcerpt. Copied fromote. Revised 12/05/23. Available at.ISBN. IIEF..eISBN[cited 12/05/23. Version].[cited 12/05/24.[cited 12/05/25.[cited 12/05/26.[cited 12/05/27.[cited 12/05/28.[cited 12/05/29.[cited 12/05/30.[cited 12/05/31.[cited 12/05/32.[cited 12/05/33.[cited 12/05/34.[cited 12/05/35.[cited 12/05/36.[cited 12/05/37.[cited 12/05/38.[cited 12/05/39.[cited 12/05/40.[cited 12/05/41.[cited 12/05/42.[cited 12/05/43.[cited 12/05/44.[cited 12/05/45.